Is Viking Therapeutics a Buy on the Dip? | The Motley Fool

5 days ago · All of this means that Viking is a compelling buy on the dip for growth investors who can tolerate some risk. Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has ...

CouponFollow Extension

531%
OFF

Got $5,000? Viking Therapeutics Stock Just Got A Big New Green …

2 weeks from now

Nov 7, 2024 · Viking Therapeutics Stock Just Got a Big New Green Flag. Alex Carchidi, The Motley Fool . Thu, Nov ... VKTX . With a gain of more than 531% over the last 12 months, …

yahoo.com

528%
OFF

Is Viking Therapeutics Stock A Buy? - MSN

2 weeks from now

The Motley Fool. Is Viking Therapeutics Stock a Buy? Story by Alex Carchidi • 6mo. W ith Viking Therapeutics (NASDAQ: VKTX) stock exploding skyward by 528% over the last 12 months, ...

msn.com

290%
OFF

Is Viking Therapeutics Stock A Buy? | The Motley Fool

2 weeks from now

May 17, 2024 · This year, shares of Viking Therapeutics are already up a staggering 290%. Investors are valuing the company at $8 billion, based primarily on the hopes that VK2735 will …

fool.com

531%
OFF

Got $5,000? Viking Therapeutics Stock Just Got A Big New Green …

2 weeks from now

Nov 7, 2024 · With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (VKTX -0.51%) are a hot commodity, to say the least. And as of early November, …

fool.com

76%
OFF

Why Viking Therapeutics Stock Plummeted After Soaring Today

2 weeks from now

Nov 4, 2024 · For high-profile biotech Viking Therapeutics (VKTX -3.76%), Monday was very much a good news/bad news kind of day. The company reported quite encouraging clinical …

fool.com

05%
OFF

Where Will Viking Therapeutics Be In 5 Years? | The Motley Fool

2 weeks from now

Oct 14, 2024 · Five years ago, Viking Therapeutics (VKTX -8.05%) was an unknown, clinical-stage biotech. It hardly stood out in a sea of small drugmakers, and most of those never end …

fool.com

$1500
OFF

Better Biotech Stock To Buy With $1,500 Right Now: Viking …

2 weeks from now

Oct 13, 2024 · Motley Fool Issues Rare “All In” Buy Alert. NASDAQ: VKTX Viking Therapeutics. Market Cap. $7B. ... Viking Therapeutics Stock Just Got a Big New Green Flag. Is Viking …

fool.com

FAQs about Is Viking Therapeutics a Buy on the Dip? | The Motley Fool Coupon?

Is Viking Therapeutics stock a buy?

Viking Therapeutics stock is jumping Thursday afternoon after the biotech company reported third quarter results that topped analyst expectations. Wall Street currently holds 13 Buy ratings on the name. Market Domination Co-Hosts Julie Hyman and Josh Lipton break down the details. ...

Should you buy Viking Therapeutics (vktx) in 2024?

Viking Therapeutics (NASDAQ: VKTX) is an anomaly of sorts. Despite another underwhelming year for biotech stocks, the metabolic disease specialist has, so far, delivered a staggering 208% return on capital for shareholders in 2024. The reason? Investors have flocked to the biotech stock in response to its experimental weight loss therapy, VK2735. ...

Is Viking Therapeutics a good anti-obesity stock?

Viking Therapeutics reported clinical trial data on Sunday, which excited some investors. Despite signs that Viking's anti-obesity candidate could be a top seller in its category, the stock fell when the market opened on Monday. The latest clinical trial data for Viking's oral anti-obesity candidate suggests it could be the best in its class. ...

Should you buy Viking pharmaceuticals?

Viking is still in the process of getting its first medicine out the door. By the looks of it, things are proceeding as planned, and within a couple of years at most, it'll be raking in sales, which is a reason to buy its stock. ...

Should you buy Viking biotech?

Viking isn't a biotech that will need to take out a lot of debt or issue a lot of new shares to get its therapies out the door. Therefore, buying its stock won't leave you at as high of a risk of your shares getting diluted by new issuance like buying many other biotech stocks would. ...

Is Viking Therapeutics worth more than its market cap in 2034?

Viking Therapeutics could be worth much more than its current market cap in 2034. It's not hard to envision a scenario where the company and its stock are thriving. After it announced great phase 2 results for VK2735, Viking said it planned to talk with the U.S. Food and Drug Administration (FDA) about the next steps for the drug's development. ...